UEF0:XETRA:XETRA-UBS Barclays US Liquid Corporates UCITS hedged to EUR A-acc (EUR)

ETF | Others |

Last Closing

USD 17.253

Change

-0.04 (-0.21)%

Market Cap

USD 0.36B

Volume

7.51K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.80 (+1.61%)

USD 502.95B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.26 (+1.62%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.42 (+1.54%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.39 (+1.50%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.52 (+2.21%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.84 (+2.08%)

USD 102.11B
JARI:XETRA Amundi Index Solutions - Amund..

+0.62 (+1.35%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.78 (+1.59%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+10.98 (+2.10%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.39 (+1.75%)

USD 79.79B

ETFs Containing UEF0:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.53% 37% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.53% 36% F 40% F
Trailing 12 Months  
Capital Gain 7.24% 42% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.24% 41% F 45% F
Trailing 5 Years  
Capital Gain -9.55% 19% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.55% 18% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain -3.47% 14% F 17% F
Dividend Return -3.47% 13% F 16% F
Total Return N/A 78% C+ 84% B
Risk Return Profile  
Volatility (Standard Deviation) 8.34% 65% D 72% C
Risk Adjusted Return -41.65% 16% F 15% F
Market Capitalization 0.36B 59% D- 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.